Making treatment decisions is a tough choice for oncologists: a therapy might save or significantly extend one patient’s life but not deliver the desired outcome for another patient.
COVID-19 drugs, vaccines and diagnostics that are developed and tested within new international guidelines can expect rapid assessment and authorisation.
Most health conditions do not discriminate based on race, color, gender or identity. However, background and identity can make access to health treatment much more difficult.